nsv5340691
- Organism: Homo sapiens
- Study:nstd200 (Abel et al. 2020)
- Variant Type:translocation
- Method Type:Sequencing
- Submitted on:GRCh37
- Variant Calls:1
- Validation:Not tested
- Clinical Assertions: No
- Region Size:1
- Publication(s):Abel et al. 2020
Source: NCBI
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 128 SVs from 27 studies. See in: genome view
Overlapping variant regions from other studies: 145 SVs from 24 studies. See in: genome view
Overlapping variant regions from other studies: 13 SVs from 10 studies. See in: genome view
Overlapping variant regions from other studies: 134 SVs from 27 studies. See in: genome view
Overlapping variant regions from other studies: 145 SVs from 24 studies. See in: genome view
Variant Region Placement Information
| Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Start | Stop | strand |
|---|---|---|---|---|---|---|---|---|---|---|
| nsv5340691 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000001.11 | Chr1 | 214,483,430 | 214,483,430 | - |
| nsv5340691 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000005.10 | Chr5 | 115,842,109 | 115,842,109 | - |
| nsv5340691 | Remapped | Perfect | GRCh38.p12 | PATCHES | Second Pass | NW_013171813.1 | Chr16|NW_0 13171813.1 | 156,620 | 156,620 | - |
| nsv5340691 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000001.10 | Chr1 | 214,656,773 | 214,656,773 | - | ||
| nsv5340691 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000005.9 | Chr5 | 115,177,806 | 115,177,806 | - |
Variant Call Information
| Variant Call ID | Type | Method | Analysis |
|---|---|---|---|
| nssv16415253 | interchromosomal translocation | Sequencing | Sequence alignment |
Variant Call Placement Information
| Variant Call ID | Placement Type | Score | Assembly | Reciprocity | Sequence ID | Chr | Start | Stop | strand |
|---|---|---|---|---|---|---|---|---|---|
| nssv16415253 | Remapped | Perfect | GRCh38.p12 | First Pass | NC_000001.11 | Chr1 | 214,483,430 | 214,483,430 | - |
| nssv16415253 | Remapped | Perfect | GRCh38.p12 | First Pass | NC_000005.10 | Chr5 | 115,842,109 | 115,842,109 | - |
| nssv16415253 | Remapped | Perfect | GRCh38.p12 | Second Pass | NW_013171813.1 | Chr16|NW_0 13171813.1 | 156,620 | 156,620 | - |
| nssv16415253 | Submitted genomic | GRCh37 (hg19) | NC_000001.10 | Chr1 | 214,656,773 | 214,656,773 | - | ||
| nssv16415253 | Submitted genomic | GRCh37 (hg19) | NC_000005.9 | Chr5 | 115,177,806 | 115,177,806 | - |
No validation data were submitted for this variant
No clinical assertion data were submitted for this variant
Genotype Information
| Variant Call ID | Allele Frequency (AF) | Allele Count (AC) | Allele Number (AN) |
|---|---|---|---|
| nssv16415253 | 0.496 | 8353 | 16834 |